• SPX
  • 5969.34
  • 0.35 %
  • 20.6299
  • DJI
  • 44296.51
  • 0.97 %
  • 426.1602
  • N225
  • 38283.85
  • 0.68 %
  • 257.6797
  • FTSE
  • 8262.08
  • 1.38 %
  • 112.8101
  • IXIC
  • 19003.65
  • 0.16 %
  • 31.2305
MAIA Biotechnology, Inc. (MAIA) Stock Price, News & Analysis

MAIA Biotechnology, Inc. (MAIA) Stock Price, News & Analysis

Currency in USD Disclaimer

$2.11

-$0.05

(-2.09%)

Day's range
$2.07
Day's range
$2.2
50-day range
$1.8
Day's range
$3.48
  • Country: US
  • ISIN: US5526411021
52 wk range
$0.82
Day's range
$5.99
  • CEO: Dr. Vlad Vitoc M.B.A., M.D.
  • Website: Visit Site


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -18.22
  • Piotroski Score 2.00
  • Grade N/A
  • Symbol (MAIA)
  • Company MAIA Biotechnology, Inc.
  • Price $2.11
  • Changes Percentage (-2.09%)
  • Change -$0.05
  • Day Low $2.07
  • Day High $2.20
  • Year High $5.99

MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded in 2018 and is headquartered in Chicago, Illinois.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 03/20/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Strong Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$1.57
  • Trailing P/E Ratio -2.46
  • Forward P/E Ratio -2.46
  • P/E Growth -2.46
  • Net Income $-19,772,905

Income Statement

Quarterly

Annual

Latest News of MAIA

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

MAIA Biotechnology, Inc. Frequently Asked Questions

  • What were the earnings of MAIA in the last quarter?

    In the last quarter MAIA Biotechnology, Inc. earnings were on Tuesday, November, 12th. The MAIA Biotechnology, Inc. maker reported -$0.11 EPS for the quarter, beating analysts' consensus estimates of -$0.32 by $0.21.

  • What is the MAIA Biotechnology, Inc. stock price today?

    Today's price of MAIA Biotechnology, Inc. is $2.11 — it has decreased by -2.09% in the past 24 hours. Watch MAIA Biotechnology, Inc. stock price performance more closely on the chart.

  • Does MAIA Biotechnology, Inc. release reports?

    Yes, you can track MAIA Biotechnology, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the MAIA Biotechnology, Inc. stock forecast?

    Watch the MAIA Biotechnology, Inc. chart and read a more detailed MAIA Biotechnology, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is MAIA Biotechnology, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on AMEX, exchange stock trades by MAIA Biotechnology, Inc. stock ticker.

  • How to buy MAIA Biotechnology, Inc. stocks?

    Like other stocks, MAIA shares are sold on stock exchanges such as AMEX. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is MAIA Biotechnology, Inc.'s EBITDA?

    MAIA Biotechnology, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in MAIA Biotechnology, Inc.’s financial statements.

  • What is the MAIA Biotechnology, Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is 0, which equates to approximately 0.00%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in MAIA Biotechnology, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including MAIA Biotechnology, Inc.'s financials relevant news, and technical analysis. MAIA Biotechnology, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for MAIA Biotechnology, Inc. stock currently indicates a “sell” signal. For more insights, review MAIA Biotechnology, Inc.’s technical analysis.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.